THC Therapeutics, Inc. Quarterly Operating Income (Loss) in USD from Q3 2010 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
THC Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q3 2010 to Q1 2024.
  • THC Therapeutics, Inc. Operating Income (Loss) for the quarter ending April 30, 2024 was -$380K, a 554% decline year-over-year.
  • THC Therapeutics, Inc. Operating Income (Loss) for the twelve months ending April 30, 2024 was -$575K, a 40.9% increase year-over-year.
  • THC Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$494K, a 71.7% increase from 2022.
  • THC Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$1.75M, a 85.8% decline from 2021.
  • THC Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$940K, a 32.4% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$575K -$380K -$322K -554% Feb 1, 2024 Apr 30, 2024 10-Q 2024-11-13
Q4 2023 -$253K -$85.2K +$189K +68.9% Nov 1, 2023 Jan 31, 2024 10-Q 2024-09-05
Q3 2023 -$442K -$55.2K +$52.3K +48.7% Aug 1, 2023 Oct 31, 2023 10-Q 2024-08-09
Q2 2023 -$494K -$54.7K +$478K +89.7% May 1, 2023 Jul 31, 2023 10-K 2024-02-26
Q1 2023 -$972K -$58K +$65.5K +53% Feb 1, 2023 Apr 30, 2023 10-Q 2024-11-13
Q4 2022 -$1.04M -$274K +$594K +68.5% Nov 1, 2022 Jan 31, 2023 10-Q 2024-09-05
Q3 2022 -$1.63M -$108K +$114K +51.5% Aug 1, 2022 Oct 31, 2022 10-Q 2024-08-09
Q2 2022 -$1.75M -$533K -$204K -62.2% May 1, 2022 Jul 31, 2022 10-K 2024-02-26
Q1 2022 -$1.54M -$124K +$46K +27.1% Feb 1, 2022 Apr 30, 2022 10-Q 2024-01-09
Q4 2021 -$1.59M -$868K -$540K -165% Nov 1, 2021 Jan 31, 2022 10-Q 2024-01-08
Q3 2021 -$1.05M -$222K -$108K -94.3% Aug 1, 2021 Oct 31, 2021 10-Q 2022-12-22
Q2 2021 -$940K -$329K -$16.4K -5.25% May 1, 2021 Jul 31, 2021 10-K 2022-11-25
Q1 2021 -$924K -$170K +$342K +66.8% Feb 1, 2021 Apr 30, 2021 10-Q 2022-06-16
Q4 2020 -$1.27M -$328K +$67K +17% Nov 1, 2020 Jan 31, 2021 10-Q 2022-05-16
Q3 2020 -$1.33M -$114K +$58.2K +33.8% Aug 1, 2020 Oct 31, 2020 10-Q 2022-05-16
Q2 2020 -$1.39M -$312K +$4.58M +93.6% May 1, 2020 Jul 31, 2020 10-K 2022-03-31
Q1 2020 -$5.97M -$511K +$18.2M +97.3% Feb 1, 2020 Apr 30, 2020 10-Q 2021-06-22
Q4 2019 -$24.2M -$395K +$2.3M +85.4% Nov 1, 2019 Jan 31, 2020 10-Q 2021-03-29
Q3 2019 -$26.5M -$172K +$235K +57.8% Aug 1, 2019 Oct 31, 2019 10-Q 2020-12-17
Q2 2019 -$26.7M -$4.89M +$628K +11.4% May 1, 2019 Jul 31, 2019 10-K 2020-11-04
Q1 2019 -$27.3M -$18.7M -$18.5M -8149% Feb 1, 2019 Apr 30, 2019 10-Q 2020-06-22
Q4 2018 -$8.85M -$2.7M -$2.56M -1812% Nov 1, 2018 Jan 31, 2019 10-Q 2020-03-23
Q3 2018 -$6.3M -$408K -$303K -290% Aug 1, 2018 Oct 31, 2018 10-Q 2019-12-23
Q2 2018 -$5.99M -$5.52M May 1, 2018 Jul 31, 2018 10-K/A 2019-11-18
Q1 2018 -$227K Feb 1, 2018 Apr 30, 2018 10-Q 2019-06-14
Q4 2017 -$141K Nov 1, 2017 Jan 31, 2018 10-Q 2019-03-15
Q3 2017 -$105K Aug 1, 2017 Oct 31, 2017 10-Q 2018-12-19
Q1 2014 -$704K -$84K -$64.5K -330% Feb 1, 2014 Apr 30, 2014 10-Q 2014-06-12
Q4 2013 -$640K -$133K -$82.1K -162% Nov 1, 2013 Jan 31, 2014 10-Q 2014-06-12
Q3 2013 -$558K -$213K -$193K -960% Aug 1, 2013 Oct 31, 2013 10-Q 2014-06-11
Q2 2013 -$365K -$274K -$48K -21.2% May 1, 2013 Jul 31, 2013 10-K 2014-06-09
Q1 2013 -$317K -$19.6K -$9.06K -86.3% Feb 1, 2013 Apr 30, 2013 10-Q 2014-06-12
Q4 2012 -$308K -$50.6K -$48.5K -2311% Nov 1, 2012 Jan 31, 2013 10-Q 2014-06-12
Q3 2012 -$259K -$20.1K -$18.7K -1337% Aug 1, 2012 Oct 31, 2012 10-Q 2014-06-11
Q2 2012 -$240K -$226K -$213K -1610% May 1, 2012 Jul 31, 2012 10-K 2014-06-09
Q1 2012 -$27.2K -$10.5K -$9.4K -860% Feb 1, 2012 Apr 30, 2012 10-Q 2012-06-14
Q4 2011 -$17.8K -$2.1K +$6.41K +75.3% Nov 1, 2011 Jan 31, 2012 10-Q 2013-03-21
Q3 2011 -$24.2K -$1.4K -$674 -92.8% Aug 1, 2011 Oct 31, 2011 10-Q 2012-12-14
Q2 2011 -$23.6K -$13.2K May 1, 2011 Jul 31, 2011 10-K 2012-11-13
Q1 2011 -$1.09K Feb 1, 2011 Apr 30, 2011 10-Q 2012-06-14
Q4 2010 -$8.51K Nov 1, 2010 Jan 31, 2011 10-Q 2012-03-21
Q3 2010 -$726 Aug 1, 2010 Oct 31, 2010 10-Q 2011-12-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.